This study aimed to evaluate the comparative effectiveness of tirzepatide versus GLP-1 RAs in reducing the risk of VTE in patients with obesity.<h4>Methods</h4>We conducted a retrospective cohort study using the TriNetX global federated health research network. The gene discussed is GLP1R; the disease is Obesity.